INmune Bio Inc. Common stock

INMB XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

38M

Short interest (May 15)

13.7%

Net Short (Jun 03 ): 0.2%

Borrow Fee

3.26%

↓ 9.9%

Available Shares

↓ 70.1%

Price Chart

Company Overview

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001711754

Asset Type: CS

Market Data

Market Cap: $37,751,066

Employees: 21

Status: Active

Short Interest

Current Borrow Fee 3.26%

Range: 2.99% - 3.26%

Available Shares 8K

Range: 6K - 250K

Recent Changes

Fee Change: ↑ 9.8%

Available Change: ↑ 222.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime